首页> 外文期刊>BMC Dermatology >Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study
【24h】

Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study

机译:角质层脂质脂质体在皮肤光动力疗法中局部递送5-氨基乙酰丙酸的用途:制备和体外渗透研究

获取原文
           

摘要

Background Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is a skin cancer therapy that still has limitations due to the low penetration of this drug into the skin. We have proposed in this work a delivery system for 5-ALA based on liposomes having lipid composition similar to the mammalian stratum corneum (SCLLs) in order to optimize its skin delivery in Photodynamic Therapy (PDT) of skin cancers. Methods SCLLs were obtained by reverse phase evaporation technique and size distribution of the vesicles was determinated by photon correlation spectroscopy. In vitro permeation profile was characterized using hairless mouse skin mounted in modified Franz diffusion cell. Results Size exclusion chromatography on gel filtration confirmed vesicle formation. SCLLs obtained by presented a degree of encapsulation of 5-ALA around 5.7%. A distribution of vesicle size centering at around 500 nm and 400 nm respectively for SCLLs and SCLLs containing 5-ALA was found. In vitro 5-ALA permeation study showed that SCLLs preparations presented higher skin retention significantly (p Conclusions The in vitro delivery performance provided by SCLLs lead to consider this systems adequate for the 5-ALA-PDT of skin cancer, since SCLLs have delivered 5-ALA to the target skin layers (viable epidermis + dermis) to be treated by topical PDT of skin cancer.
机译:背景技术使用5-氨基乙酰丙酸(5-ALA)的光动力疗法(PDT)是一种皮肤癌疗法,由于该药物向皮肤的渗透率较低,因此仍然存在局限性。我们在这项工作中提出了一种基于脂质体的5-ALA递送系统,该脂质体的脂质组成类似于哺乳动物角质层(SCLLs),以便在皮肤癌的光动力疗法(PDT)中优化其皮肤递送。方法采用反相蒸发技术获得SCLL,并通过光子相关光谱法确定囊泡的大小分布。使用安装在改良的Franz扩散池中的无毛小鼠皮肤表征体外渗透曲线。结果在凝胶过滤上的尺寸排阻色谱法证实了囊泡的形成。通过获得的SCLL呈现5-ALA的包囊度约5.7%。发现SCLL和含有5-ALA的SCLL的囊泡大小分布分别以500nm和400nm为中心。体外5-ALA渗透研究表明,SCLLs制剂具有较高的皮肤滞留性(p结论SCLLs提供的体外递送性能使该系统适合皮肤癌的5-ALA-PDT,因为SCLLs递送了5-ALA-PDT。通过皮肤癌的局部PDT治疗目标皮肤层(活表皮+真皮)的ALA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号